Inhibition of CD36 palmitoylation reduces FA binding/uptake and activates the AMPK pathway, thus ameliorates intracellular lipid accumulation and prevents NASH development 62 (Figure 3a). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.